Clinical Trial Update: Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases

View source ↗

Summary

This clinical trial update reports on the investigation of Gallium-68 labeled FAPI PET imaging combined with Cardiac Magnetic Resonance (CMR) for cardiovascular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• 68Ga-FAPI PET/CMR (Gallium-68 labeled fibroblast activation protein inhibitor for PET/CMR imaging)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Cardiovascular Diseases (CVD) | Status: RECRUITING